17 November 2020

During this hour-long panel discussion at Pharma Integrates 2020, tranScrip's Managing Partner, Flic Gabbay, joined other health care professionals to explore what we are doing differently now that’s better than before and what we foresee might be future benefits of new ways of working.

Facilitated by:
- Tina Flatau, Chief Executive Officer, Biopharma Projects

Speakers included:
- David Hawkins, Founder and Chief Executive Officer, Remedium Capital
- Flic Gabbay, Managing Partner, tranScrip
Graham Wylie, Chief Executive Officer, MRN
- Helen Barker, Head of Pharmaceutical Development, Reneo Pharma
- Sean Breen, Head Public Private Partnerships and Science Policy, Takeda

You can view all Pharma Integrates 2020 recordings here.